Woroń , Jarosław. 2020. “SGLT2 Inhibitors – Why a Synthesis of Empagliflozin Is a Significant Progression in Diabetes Pharmacotherapy?”. Medycyna Faktow (J EBM) 13 (2(47), 147-50. https://doi.org/10.24292/01.MF.0220.2.